Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
1.820
-0.010 (-0.55%)
At close: May 18, 2026, 4:00 PM EDT
1.820
0.00 (0.00%)
Pre-market: May 19, 2026, 5:04 AM EDT
Tempest Therapeutics Market Cap
Tempest Therapeutics has a market cap or net worth of $26.11 million as of May 19, 2026. Its market cap has increased by 6.09% in one year.
Market Cap
26.11M
Enterprise Value
32.16M
1-Year Change
6.09%
Ranking
Category
Stock Price
$1.82
Market Cap Chart
Since June 28, 2021, Tempest Therapeutics's market cap has decreased from $88.65M to $26.11M, a decrease of -70.55%. That is a compound annual growth rate of -22.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 26.11M | 84.61% |
| Dec 31, 2025 | 14.14M | -61.17% |
| Dec 31, 2024 | 36.42M | -57.00% |
| Dec 29, 2023 | 84.69M | 600.22% |
| Dec 30, 2022 | 12.09M | -66.85% |
| Dec 31, 2021 | 36.49M | -58.84% |
| Jun 28, 2021 | 88.65M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Barinthus Biotherapeutics | 27.76M |
| Polyrizon | 27.70M |
| Kyntra Bio | 27.61M |
| Sensei Biotherapeutics | 27.38M |
| ABVC BioPharma | 26.93M |
| Dyadic International | 26.31M |
| Palatin Technologies | 26.03M |
| Neuphoria Therapeutics | 25.50M |